Table 4. Dosage and pharmacological characteristics of tramadol and tapentadol [81,91,114].
| Drug | Species | Doses | Route | Mechanism of action | Adverse effects |
|---|---|---|---|---|---|
| Tramadol | Dogs | 4–10 mg/kg/6–8 h | IV, IM, PO | Agonism to μ-receptors Inhibits monoamine reuptake (NE and 5-HT) |
Tremors, myoclonus, tachycardia, agitation, excitement, hypertension, and seizures (signs of serotonin toxicity) |
| Cats | 1–4 mg/kg/12–24 h | IM, IV, PO | |||
| Tapentadol* | Dogs | 2–30 mg/kg | IV, PO | μ-Opioid receptor agonist NRI |
Salivation, agitation, panting, mydriasis, euphoria, and sedation |
| Cats | 5–10 mg/kg q 12 h | IV, IM, PO, SC |
PO = oral.
doses taken from the available literature.